| Effect | None |
| Trial Design | Double blind |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 16 |
| Sex | Both Genders |
| Age Range | 30-44 |
| Body Types | Overweight, Average |
In patients with fatty liver, melatonin supplementation at 10mg improved insulin sensitivity and increased circulating adipokines. The decrease in insulin failed to reach significance, while liver enzymes were reduced in the liver fat group only (healthy controls, for comparison, had no such decrease)
